Sharon Cunningham

Title: The Innovative Mind of Sharon Cunningham

Introduction

Sharon Cunningham, based in County Tipperary, Ireland, is an accomplished inventor known for her contributions to pharmaceutical formulations. With a focus on enhancing medication stability and efficacy, her research paves the way for advancements in cancer treatment.

Latest Patents

Cunningham holds a patent for "Stable formulations comprising thiotepa." The innovative pharmaceutical composition integrates thiotepa with polyethylene glycol (PEG), such as PEG400 or PEG600, alongside DMSO, and optionally water or an aqueous saline solution and thiosulfate. This formulation is noteworthy for being free or substantially free of impurities. Additionally, the patent outlines a method intended for treating cancer or conducting myeloablation prior to bone marrow transplantation utilizing this specialized composition. An emphasis is also placed on enhancing the stability of the thiotepa formulation.

Career Highlights

Sharon Cunningham has made significant strides in the pharmaceutical industry, demonstrating her commitment to improving therapeutic options for patients. Her inventive work has not only led to a patented formulation but has also established her position as a key player in her field.

Collaborations

Throughout her career, Cunningham has collaborated with notable colleagues such as Orlaith Ryan and Johannes Jan Platteeuw. Their partnerships enhance the innovation process, furthering the development of novel pharmaceutical solutions.

Conclusion

Sharon Cunningham's pioneering work in the formulation of thiotepa reflects her dedication to advancing cancer treatment options. As an inventor with a clear focus on pharmaceutical stability and effectiveness, she continues to play an essential role in the field, promising a brighter future for patients relying on these innovative treatments.